The role of pneumonia and secondary bacterial infection in fatal and serious outcomes of pandemic influenza a(H1N1)pdm09.
Open accessAbstract
BACKGROUND: The aim of this study was to estimate the prevalence of pneumonia and secondary bacterial infections during the pandemic of influenza A(H1N1)pdm09. METHODS: A systematic review was conducted to identify relevant literature in which clinical outcomes of pandemic influenza A(H1N1)pdm09 infection were described. Published studies (between 01/01/2009 and 05/07/2012) describing cases of fatal or hospitalised A(H1N1)pdm09 and including data on bacterial testing or co-infection. RESULTS: Seventy five studies met the inclusion criteria. Fatal cases with autopsy specimen testing were reported in 11 studies, in which any co-infection was identified in 23% of cases (Streptococcus pneumoniae 29%). Eleven studies reported bacterial co-infection among hospitalised cases of A(H1N1)2009pdm with confirmed pneumonia, with a mean of 19% positive for bacteria (Streptococcus pneumoniae 54%). Of 16 studies of intensive care unit (ICU) patients, bacterial co-infection identified in a mean of 19% of cases (Streptococcus pneumoniae 26%). The mean prevalence of bacterial co-infection was 12% in studies of hospitalised patients not requiring ICU (Streptococcus pneumoniae 33%) and 16% in studies of paediatric patients hospitalised in general or pediatric intensive care unit (PICU) wards (Streptococcus pneumoniae 16%). CONCLUSION: We found that few studies of the 2009 influenza pandemic reported on bacterial complications and testing. Of studies which did report on this, secondary bacterial infection was identified in almost one in four patients, with Streptococcus pneumoniae the most common bacteria identified. Bacterial complications were associated with serious outcomes such as death and admission to intensive care. Prevention and treatment of bacterial secondary infection should be an integral part of pandemic planning, and improved uptake of routine pneumococcal vaccination in adults with an indication may reduce the impact of a pandemic.
AI snapshot
Written from the paper’s full text.
TL;DR
This systematic review of 75 studies found that secondary bacterial infection complicated a substantial minority of severe or fatal pandemic influenza A(H1N1)pdm09 cases, with Streptococcus pneumoniae the most commonly identified pathogen. The authors conclude that bacterial complications were associated with death and ICU admission, and that prevention and treatment of secondary bacterial infection should be part of pandemic planning.
Key findings
- Among fatal cases with autopsy specimen testing, any co-infection was identified in 23% of cases, with Streptococcus pneumoniae in 29%.
- Among hospitalised cases with confirmed pneumonia, a mean of 19% tested positive for bacteria, with Streptococcus pneumoniae in 54%; among ICU patients, bacterial co-infection was identified in a mean of 19%, with Streptococcus pneumoniae in 26%.
- Mean bacterial co-infection prevalence was 12% in hospitalised patients not requiring ICU (Streptococcus pneumoniae 33%) and 16% in paediatric patients hospitalised in general or PICU wards (Streptococcus pneumoniae 16%).
- The overall rate of bacterial infection was significantly higher in fatal versus nonfatal cases (OR 1.71, 95% CI 1.33–2.20), and S. pneumoniae co-infection was associated with higher mortality in one large Argentina ICU study (OR 2.72, 95% CI 1.05–7.06) despite concurrent antibiotics.
Methods
- Systematic review conducted according to PRISMA, searching Medline, Pre-Medline, EmBASE and LILACS for English-language human studies published 01/01/2009–05/07/2012, plus hand-searching reference lists.
- Included observational studies reporting ≥10 influenza A(H1N1)pdm09 patients with bacterial infections at any sterile site, restricted to fatal or hospitalised confirmed/probable cases; excluded specific at-risk populations, case reports/series <10, and ambulatory cases without hospital admission or death outcomes.
- From 7845 identified studies, 75 met inclusion criteria; data were extracted independently by two reviewers, with discrepancies resolved by a senior reviewer. Variability precluded quantitative meta-analysis, so results were summarised separately for fatal cases, hospitalised pneumonia cases, ICU patients, general ward patients, and paediatric patients.
Limitations
- The paper states that variability of available data precluded quantitative meta-analysis, that many studies did not clarify whether pneumonia was community- or hospital-acquired, and that samples and timing of sampling were not adequately described in most studies.
- The paper states that bacterial co-infection may be underestimated because many cases were not tested, bacterial pneumonia cannot always be differentiated from viral pneumonia by clinical presentation, radiology, and routine blood tests, and no standardised testing protocol existed for fatal cases.
- Evident from the text: included studies were heterogeneous observational designs with varying definitions and testing proportions, some included probable rather than PCR-confirmed cases, and the search was limited to English-language publications up to 2012.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
0 of 59 cited sources checked · 0 supported · 0 flagged
- Findingcitation
Among fatal A(H1N1)pdm09 cases with autopsy specimen testing, any bacterial co-infection was identified in a mean of 23% of cases.
“Fatal cases with autopsy specimen testing were reported in 11 studies, in which any co-infection was identified in 23% of cases”
- Also stated in: § Bacterial co-infection among fatal cases of A(H1N1)2009pdm · plain
“positive bacterial growth ranged from 2 to 38% (mean bacterial 23%) [9] of autopsied cases.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [9] Madhi SA, Klugman KP. A role for Streptococcus pneumoniae in virus-associated pneumonia. Nat Med. 2004;10:811–3 Epub 2004/07/13. source
Not checked in the free run.
- Also stated in: § Bacterial co-infection among fatal cases of A(H1N1)2009pdm · plain
- Findingown data
Among hospitalised A(H1N1)pdm09 patients not requiring ICU, the mean prevalence of bacterial co-infection was 12%.
“The mean prevalence of bacterial co-infection was 12% in studies of hospitalised patients not requiring ICU”
- Also stated in: § Bacterial co-infection reported among hospitalised cases of influenza A(H1N1)pdm09, not requiring ICU · plain
“any positive bacterial growth was reported in 1.6–76% cases (mean bacterial 12%, Streptococcus pneumoniae 33%).”
Quote in the paperNot a substantial claim - Also stated in: § Bacterial co-infection reported among hospitalised cases of influenza A(H1N1)pdm09, not requiring ICU · plain
- Findingown data
Streptococcus pneumoniae was the most common bacteria identified in secondary bacterial infections in the 2009 influenza pandemic.
“with Streptococcus pneumoniae the most common bacteria identified.”
Quote in the paperSubstantial claim - Findingcitation
In a Canadian study (N=168), secondary bacterial infection was attributed as a leading cause of death in the 29 (17.3%) fatalities.
“A Canadian study (N = 168) attributed secondary bacterial infection as a leading cause of death in the 29 (17.3%) fatalities that occurred in this cohort [33].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [33] Kumar A, Zarychanski R, Pinto R, et al. Critically ill patients with 2009 influenza A(H1N1) infection in Canada. JAMA. 2009;302:1872–9. source
Not checked in the free run.
- Findingown data
Among hospitalised A(H1N1)pdm09 cases with confirmed pneumonia and positive bacterial testing, Streptococcus pneumoniae was the most commonly isolated pathogen, at 54%.
“Streptococcus pneumoniae 54%”
- Also stated in: § Bacterial co-infection among hospitalised cases of A(H1N1)2009pdm with confirmed pneumonia · plain
“Streptococcus pneumoniae was the most commonly isolated pathogen (54%).”
Quote in the paperNot a substantial claim - Also stated in: § Bacterial co-infection among hospitalised cases of A(H1N1)2009pdm with confirmed pneumonia · plain
- Findingown data
Among hospitalised A(H1N1)pdm09 patients not requiring ICU with bacterial co-infection, Streptococcus pneumoniae accounted for 33%.
“Streptococcus pneumoniae 33%”
- Also stated in: § Bacterial co-infection reported among hospitalised cases of influenza A(H1N1)pdm09, not requiring ICU · plain
“Streptococcus pneumoniae 33%”
Quote in the paperNot a substantial claim - Also stated in: § Bacterial co-infection reported among hospitalised cases of influenza A(H1N1)pdm09, not requiring ICU · plain
- Findingown data
Among ICU-admitted A(H1N1)pdm09 cases with bacterial co-infection, Streptococcus pneumoniae accounted for 26%.
“Streptococcus pneumoniae 26%”
- Also stated in: § Bacterial co-infection reported among severe cases of A(H1N1)pdm09 admitted to ICUs · plain
“Streptococcus pneumoniae 26%”
Quote in the paperNot a substantial claim - Also stated in: § Bacterial co-infection reported among severe cases of A(H1N1)pdm09 admitted to ICUs · plain
- Findingcitation
Bacterial infection complicating A(H1N1)pdm09 ranged from 5 to 14% of fatal cases in the four studies reporting data from clinical testing prior to death.
“On this basis, bacterial infection complicating A(H1N1)pdm09 ranged from 5 to 14% of fatal cases in the four studies [1, 17, 21, 22] reporting data from clinical testing prior to death”
Quote in the paperSubstantial claim0 of 4 sources checked- cites [1] Lee EH, Wu C, Lee EU, et al. Fatalities associated with the 2009 H1N1 influenza A virus in New York city. Clin Infect Dis. 2010;50:1498–504. source
Not checked in the free run.
- cites [17] Mauad T, Hajjar LA, Callegari GD, et al. Lung pathology in fatal novel human influenza A (H1N1) infection. Am J Respir Crit Care Med. 2010;181:72–9. source
Not checked in the free run.
- cites [21] Nakajima N, Sato Y, Katano H, et al. Histopathological and immunohistochemical findings of 20 autopsy cases with 2009 H1N1 virus infection. Mod Pathol. 2012;25:1–13. source
Not checked in the free run.
- cites [22] Tamme K, Minajeva A, Adamson V, et al. Clinical and pathological findings of fatal 2009-2010 pandemic influenza A (H1N1) infection in Estonia. Medicina (Kaunas). 2012;48:48–56. source
Not checked in the free run.
- Findingcitation
S. pneumoniae co-infection was associated with higher mortality (OR 2.72, 95% CI 1.05-7.06) in ICU patients with influenza, despite concurrent antibiotic treatment on admission.
“S.pneumoniae co-infection was associated with higher mortality (OR 2.72 95% CI 1.05–7.06), despite concurrent antibiotic treatment on admission [5].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [5] Estenssoro E, Rios FG, Apezteguia C, et al. Pandemic 2009 influenza A in Argentina: a study of 337 patients on mechanical ventilation. Am J Respir Crit Care Med. 2010;182:41–8. source
Not checked in the free run.
- Findingnone given
Samples and time of sampling were not adequately described in most of the studies.
“Samples and time of sampling were not adequately described in most of the studies.”
Quote in the paperNot a substantial claim - Findingown data
Among fatal A(H1N1)pdm09 cases with bacterial co-infection, Streptococcus pneumoniae accounted for 29% of coinfection cases.
“Of the total coinfection cases, 29% were Streptococcus pneumoniae.”
- Also stated in: § Results · plain
“Streptococcus pneumoniae 29%”
Quote in the paperNot a substantial claim - Also stated in: § Results · plain
- Findingown data
Among hospitalised A(H1N1)pdm09 cases with confirmed pneumonia, the mean prevalence of positive bacterial testing was 19%.
“Eleven studies reported bacterial co-infection among hospitalised cases of A(H1N1)2009pdm with confirmed pneumonia, with a mean of 19% positive for bacteria”
- Also stated in: § Bacterial co-infection among hospitalised cases of A(H1N1)2009pdm with confirmed pneumonia · plain
“positive bacterial growth was ranged from 0 to 47% (mean 19%).”
Quote in the paperNot a substantial claim - Also stated in: § Bacterial co-infection among hospitalised cases of A(H1N1)2009pdm with confirmed pneumonia · plain
- Findingown data
Reporting of patient clinical outcomes, bacterial testing and bacterial findings varied widely in the included published studies.
“Reporting of patient clinical outcomes, bacterial testing and bacterial findings varied widely in the included published studies.”
Quote in the paperSubstantial claim - Findingown data
Among paediatric A(H1N1)pdm09 patients hospitalised in general or PICU wards with bacterial co-infection, Streptococcus pneumoniae accounted for 16%.
“(Streptococcus pneumoniae 16%)”
Quote in the paperNot a substantial claim - Findingreasoning
No studies gave a complete picture of pulmonary bacterial co-infection during the clinical course and corresponding post-mortem findings.
“No studies gave a complete picture of pulmonary bacterial co-infection during the clinical course and corresponding post-mortem findings.”
Quote in the paperSubstantial claim - Findingown data
Among ICU-admitted A(H1N1)pdm09 cases, the mean prevalence of bacterial co-infection was 19%.
“Of 16 studies of intensive care unit (ICU) patients, bacterial co-infection identified in a mean of 19% of cases”
- Also stated in: § Bacterial co-infection reported among severe cases of A(H1N1)pdm09 admitted to ICUs · plain
“bacterial co-infection was identified in 1–43% of cases (mean bacterial 19%, Streptococcus pneumoniae 26%).”
Quote in the paperNot a substantial claim - Also stated in: § Bacterial co-infection reported among severe cases of A(H1N1)pdm09 admitted to ICUs · plain
- Findingown data
Among studies that reported on bacterial complications, secondary bacterial infection was identified in almost one in four patients.
“Of studies which did report on this, secondary bacterial infection was identified in almost one in four patients”
Quote in the paperSubstantial claim - Findingown data
The overall rate of bacterial infection was significantly higher in fatal cases compared to nonfatal cases (OR 1.71, 95% CI 1.33 to 2.20).
“The overall rate of bacterial infection was significantly higher in fatal cases compared to nonfatal cases (OR 1.71, 95% CI 1.33 to 2.20).”
Quote in the paperSubstantial claim - Findingown data
Among paediatric A(H1N1)pdm09 patients hospitalised in general or PICU wards, the mean prevalence of bacterial co-infection was 16%.
“16% in studies of paediatric patients hospitalised in general or pediatric intensive care unit (PICU) wards”
Quote in the paperNot a substantial claim - Findingreasoning
No studies had a standardised testing protocol for all included fatal cases.
“no studies had a standardised testing protocol for all included fatal cases.”
Quote in the paperSubstantial claim - Findingown data
Few studies of the 2009 influenza pandemic reported on bacterial complications and testing.
“We found that few studies of the 2009 influenza pandemic reported on bacterial complications and testing.”
Quote in the paperSubstantial claim - Findingcitation
Of the 11 studies of hospitalised cases with confirmed pneumonia, 2 reported no evidence of bacterial co-infection in their cohort.
“Of the 11 studies, 2 reported no evidence of bacterial co-infection in their cohort of patients [4, 23], however, neither reported the proportion of patients tested.”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [4] Busi RE, Schinina V, Ferraro F, et al. Radiological findings of pneumonia in patients with swine-origin influenza A virus (H1N1). Radiol Med. 2010;115:507–15. source
Not checked in the free run.
- cites [23] Perez-Padilla R, De La Rosa-Zamboni D, Ponce De Leon S, et al. Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico. N Engl J Med. 2009;361:680–9. source
Not checked in the free run.
- Findingown data
The number of patients with S. pneumoniae co-infection varied from 1 to 31% depending on site of sample.
“The number of patients with S.pneumoniae co-infection varied from 1 to 31% depending on site of sample.”
Quote in the paperNot a substantial claim - Findingcitation
In the first 100 confirmed deaths in Mexico, only 2 cases had positive bacterial cultures (Staphylococcus epidermidis and Staphylococcus hominis).
“The lowest proportion of co-infection was reported in the first 100 confirmed deaths in Mexico [14] where 94% of patients had multiple foci of pneumonia (based on imaging) and 84% required mechanical ventilation, and only 2 cases had positive bacterial cultures (Staphylococcus epidermidis and Staphylococcus hominis).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [14] Fajardo-Dolci G, Gutierrez-Vega R, Arboleya-Casanova H, et al. Clinical characteristics of fatalities due to influenza A (H1N1) virus in Mexico. Thorax. 2010;65:505–9. source
Not checked in the free run.
- Findingcitation
One study reported that the ARDS-death group was more likely to have bacterial co-infections than patients who survived without ARDS or had mild disease.
“One study reported factors associated with acute respiratory distress syndrome (ARDS) or death, with the ARDS-death group more likely to have bacterial co-infections than patients who survived without ARDS or had mild disease [25].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [25] Ugarte S, Arancibia F, Soto R. Influenza A pandemics: clinical and organizational aspects: the experience in Chile. Crit Care Med. 2010;38(4 Suppl):e133–7. source
Not checked in the free run.
- Findingcitation
The highest proportion of culture positive bacterial co-infection from autopsy samples (38%) was reported by Tamme.
“The highest proportion of culture positive bacterial co-infection from autopsy samples (38%) was reported by Tamme [22].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [22] Tamme K, Minajeva A, Adamson V, et al. Clinical and pathological findings of fatal 2009-2010 pandemic influenza A (H1N1) infection in Estonia. Medicina (Kaunas). 2012;48:48–56. source
Not checked in the free run.
- Findingcitation
Six studies reported use of antibiotics prior to specimen collection in subjects with bacterial co-infection in 21-22% of those tested.
“Six studies reported use of antibiotics prior to specimen collection in subjects with bacterial co-infection in 21–22% of those tested [23, 24].”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [23] Perez-Padilla R, De La Rosa-Zamboni D, Ponce De Leon S, et al. Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico. N Engl J Med. 2009;361:680–9. source
Not checked in the free run.
- cites [24] Cui W, Zhao H, Lu X, et al. Factors associated with death in hospitalized pneumonia patients with 2009 H1N1 influenza in Shenyang, China. BMC Infect Dis. 2010;10:145. source
Not checked in the free run.
- Findingnone given
In ICU patients, ventilator associated pneumonia with organisms such as Acinetobacter baumannii, Achromobacter xylosoxidans, methicillin-resistant Staphylococcus aureus, and Escherichia coli was common.
“in ICU patients, ventilator associated pneumonia with organisms such as Acinetobacter baumannii, Achromobacter xylosoxidans, methicillin-resistant Staphylococcus aureus, and Escherichia coli was common”
Quote in the paperNot a substantial claim - Findingown data
Streptococcus pneumoniae was the most common bacteria identified in secondary bacterial infections during the 2009 influenza pandemic.
“Streptococcus pneumoniae was the most common bacteria identified, and in ICU patients, ventilator associated pneumonia with organisms such as Acinetobacter baumannii, Achromobacter xylosoxidans, methicillin-resistant Staphylococcus aureus, and Escherichia coli was common.”
- Also stated in: § Conclusion · plain
“with Streptococcus pneumoniae the most common bacteria identified”
Quote in the paperSubstantial claim - Also stated in: § Conclusion · plain
- Findingnone given
Almost 1 in 4 severe or fatal cases of 2009 pandemic influenza had bacterial secondary infections.
“with almost 1 in 4 severe or fatal cases having bacterial secondary infections, albeit with varying rates”
Quote in the paperSubstantial claim - Findingown data
Bacterial co-infection rate among hospitalised cases with confirmed pneumonia in this review was 19%.
“Bacterial co-infection rates among hospitalised cases with confirmed pneumonia in this study was 19%, which is comparable to Chien et al.”
Quote in the paperNot a substantial claim - Findingnone given
Testing for bacterial complications during an influenza pandemic was neglected in most studies screened for this review.
“Testing for bacterial complications during an influenza pandemic is important, but was neglected in most studies which we screened for this review.”
Quote in the paperSubstantial claim - Findingown data
Rates of bacterial co-infections in paediatric studies ranged from 13-34% (mean 32%) in admission to PICU.
“Rates of bacterial co-infections vary in these studies, ranging from 0 to 87% (mean 5%) in any hospital ward admission to 13–34% (mean 32%) in admission to PICU.”
Quote in the paperNot a substantial claim - Findingown data
Rates of bacterial co-infections in paediatric studies ranged from 0 to 87% (mean 5%) in any hospital ward admission.
“Rates of bacterial co-infections vary in these studies, ranging from 0 to 87% (mean 5%) in any hospital ward admission to 13–34% (mean 32%) in admission to PICU.”
Quote in the paperNot a substantial claim - Findingcitation
The highest rate of bacterial co-infection in paediatric studies was reported by Okada [43] in Japan on 46 hospitalised children from July 2009 to January 2010.
“The highest rate was reported by Okada [43] who conducted a study in Japan on 46 hospitalised children from July 2009 to January 2010.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [43] Okada T, Morozumi M, Matsubara K, et al. Characteristic findings of pediatric inpatients with pandemic (H1N1) 2009 virus infection among severe and nonsevere illnesses. J Infect Chemother. 2011;17:238–45. source
Not checked in the free run.
- Findingcitation
In Okada's study, S. pneumoniae was isolated in 37.0% of cases.
“S. pneumoniae 37.0%; S. pneumoniae and H. influenzae 23.9%, H. influenza, 26.1% and S. aureus 23.9%”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [43] Okada T, Morozumi M, Matsubara K, et al. Characteristic findings of pediatric inpatients with pandemic (H1N1) 2009 virus infection among severe and nonsevere illnesses. J Infect Chemother. 2011;17:238–45. source
Not checked in the free run.
- Findingown data
The mean prevalence of bacterial co-infection was 16% in studies of paediatric patients hospitalised in general or pediatric intensive care unit (PICU) wards.
“The mean prevalence of bacterial co-infection was 16% in studies of paediatric patients hospitalised in general or pediatric intensive care unit (PICU) wards.”
Quote in the paperNot a substantial claim - Findingcitation
Bacteria were isolated from nasopharyngeal swabs of 87% of admitted cases (40/46) in Okada's study.
“Bacteria were isolated from nasopharyngeal swabs of 87% admitted cases (40/46)- S. pneumoniae 37.0%; S. pneumoniae and H. influenzae 23.9%, H. influenza, 26.1% and S. aureus 23.9%.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [43] Okada T, Morozumi M, Matsubara K, et al. Characteristic findings of pediatric inpatients with pandemic (H1N1) 2009 virus infection among severe and nonsevere illnesses. J Infect Chemother. 2011;17:238–45. source
Not checked in the free run.
- Findingown data
The highest risk of bacterial infection was for fatal and ICU admitted cases.
“showing the highest risk of bacterial infection for fatal and ICU admitted cases”
Quote in the paperSubstantial claim - Findingown data
Severe and fatal cases of influenza during the 2009 pandemic did comprise secondary bacterial causes, including Streptococcus pneumoniae as a contributing factor.
“We have found evidence that severe and fatal cases of influenza during the 2009 pandemic did comprise secondary bacterial causes, including streptococcus pneumoniae as a contributing factor.”
Quote in the paperSubstantial claim - Findingcitation
In Okada's study, S. pneumoniae and H. influenzae were isolated in 23.9% of cases.
“S. pneumoniae 37.0%; S. pneumoniae and H. influenzae 23.9%, H. influenza, 26.1% and S. aureus 23.9%”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [43] Okada T, Morozumi M, Matsubara K, et al. Characteristic findings of pediatric inpatients with pandemic (H1N1) 2009 virus infection among severe and nonsevere illnesses. J Infect Chemother. 2011;17:238–45. source
Not checked in the free run.
- Findingcitation
In Okada's study, H. influenzae was isolated in 26.1% of cases.
“S. pneumoniae 37.0%; S. pneumoniae and H. influenzae 23.9%, H. influenza, 26.1% and S. aureus 23.9%”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [43] Okada T, Morozumi M, Matsubara K, et al. Characteristic findings of pediatric inpatients with pandemic (H1N1) 2009 virus infection among severe and nonsevere illnesses. J Infect Chemother. 2011;17:238–45. source
Not checked in the free run.
- Findingcitation
In Okada's study, S. aureus was isolated in 23.9% of cases.
“S. pneumoniae 37.0%; S. pneumoniae and H. influenzae 23.9%, H. influenza, 26.1% and S. aureus 23.9%”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [43] Okada T, Morozumi M, Matsubara K, et al. Characteristic findings of pediatric inpatients with pandemic (H1N1) 2009 virus infection among severe and nonsevere illnesses. J Infect Chemother. 2011;17:238–45. source
Not checked in the free run.
- Study design and conductown data
The variability of the available data precluded the aggregation of results in a quantitative meta-analysis.
“The variability of the available data precluded the aggregation of results in a quantitative meta-analysis.”
Quote in the paperSubstantial claim - Interpretationown data
Bacterial complications were associated with serious outcomes such as death and admission to intensive care.
“Bacterial complications were associated with serious outcomes such as death and admission to intensive care.”
Quote in the paperSubstantial claim - Study design and conductnone given
Influenza A(H1N1)pdm09 infection was confirmed by rtPCR in either ante-mortem nasopharyngeal swab or post-mortem lung tissue specimens for all cases in all studies.
“Influenza A(H1N1)pdm09 infection was confirmed by reverse transcriptase polymerase chain reaction (rtPCR) in either ante-mortem nasopharyngeal swab or post-mortem lung tissue specimens for all cases in all studies.”
Quote in the paperSubstantial claim - Interpretationreasoning
Bacterial infection appeared to be associated with morbidity and mortality in 2009 pandemic influenza.
“Bacterial infection appeared to be associated with morbidity and mortality, with higher rates in adults, ICU patients and those with a fatal outcome.”
- Also stated in: § Conclusion · hedged
“Bacterial infection appeared to be associated with morbidity and mortality, with higher rates in adults, ICU patients and those with a fatal outcome.”
Quote in the paperSubstantial claim - Also stated in: § Conclusion · hedged
- Interpretationown data
Secondary bacterial infection was an important complication of the 2009 influenza pandemic.
“Secondary bacterial infection was an important complication of the 2009 influenza pandemic, with almost 1 in 4 severe or fatal cases having bacterial secondary infections, albeit with varying rates.”
- Also stated in: § Conclusion · plain
“We found that secondary bacterial infection was an important complication of the 2009 influenza pandemic, with Streptococcus pneumoniae the most common bacteria identified.”
Quote in the paperSubstantial claim - Also stated in: § Conclusion · plain
- Premisecitation
Two early reviews of severe 2009 pandemic influenza A(H1N1) showed no evidence of bacterial pneumonia among 30 hospitalized patients in California and 10 intensive-care patients in Michigan.
“However, two early reviews of severe cases of 2009 pandemic influenza A (H1N1) showed no evidence of bacterial pneumonia among 30 hospitalized patients with laboratory-confirmed cases in California (5) and 10 intensive-care patients in Michigan (6).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [5] Estenssoro E, Rios FG, Apezteguia C, et al. Pandemic 2009 influenza A in Argentina: a study of 337 patients on mechanical ventilation. Am J Respir Crit Care Med. 2010;182:41–8. source
Not checked in the free run.
- cites [6] Chitnis AS, Truelove SA, Druckenmiller JK, Heffernan RT, Davis JP. Epidemiologic and clinical features among patients hospitalized in Wisconsin with 2009 H1N1 influenza A virus infections, April to August 2009. WMJ. 2010;109:201–8.
Not checked in the free run.
- Premisecitation
Evidence from seasonal influenza epidemics, past pandemics, pathology studies and animal models shows influenza predisposes to bacterial co-infection.
“Evidence of influenza predisposing to bacterial co-infection is seen in seasonal influenza epidemics, past pandemics, pathology studies and animal models [1–8].”
Quote in the paperSubstantial claim0 of 8 sources checked- cites [1] Lee EH, Wu C, Lee EU, et al. Fatalities associated with the 2009 H1N1 influenza A virus in New York city. Clin Infect Dis. 2010;50:1498–504. source
Not checked in the free run.
- cites [2] Gill JR, Sheng ZM, Ely SF, et al. Pulmonary pathologic findings of fatal 2009 pandemic influenza A/H1N1 viral infections. Arch Pathol Lab Med. 2010;134:235–43. source
Not checked in the free run.
- cites [3] Chien YS, Su CP, Tsai HT, et al. Predictors and outcomes of respiratory failure among hospitalized pneumonia patients with 2009 H1N1 influenza in Taiwan. J Inf Secur. 2010;60:168–74.
Not checked in the free run.
- cites [4] Busi RE, Schinina V, Ferraro F, et al. Radiological findings of pneumonia in patients with swine-origin influenza A virus (H1N1). Radiol Med. 2010;115:507–15. source
Not checked in the free run.
- cites [5] Estenssoro E, Rios FG, Apezteguia C, et al. Pandemic 2009 influenza A in Argentina: a study of 337 patients on mechanical ventilation. Am J Respir Crit Care Med. 2010;182:41–8. source
Not checked in the free run.
- cites [6] Chitnis AS, Truelove SA, Druckenmiller JK, Heffernan RT, Davis JP. Epidemiologic and clinical features among patients hospitalized in Wisconsin with 2009 H1N1 influenza A virus infections, April to August 2009. WMJ. 2010;109:201–8.
Not checked in the free run.
- cites [7] Louie JK, Gavali S, Acosta M, et al. Children hospitalized with 2009 novel influenza A(H1N1) in California. Arch Pediatr Adolesc Med. 2010;164:1023–31. source
Not checked in the free run.
- cites [8] Jouvet P, Hutchison J, Pinto R, et al. Critical illness in children with influenza A/pH1N1 2009 infection in Canada. Pediatr Crit Care Med. 2010;11:603–9. source
Not checked in the free run.
- Premisecitation
During the 1918 pandemic, bacterial pneumonia was a major cause of morbidity and mortality.
“During the 1918 pandemic, bacterial pneumonia was a major cause of morbidity and mortality, as shown by studies at the time as well as retrospective study of pathology specimens [10, 11].”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [10] Morens DM, Taubenberger JK, Fauci AS. Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness. J Infect Dis. 2008;198:962–70 Epub 2008/08/20. source
Not checked in the free run.
- cites [11] Brundage JF, Shanks GD. Deaths from bacterial pneumonia during 1918-19 influenza pandemic. Emerg Infect Dis. 2008;14:1193–9 Epub 2008/08/06. source
Not checked in the free run.
- Premisecitation
The most important bacterial co-infections during an influenza pandemic are S. pneumoniae, H. influenzae, S. aureus, and group A Streptococcus.
“The most important bacterial co-infections during an influenza pandemic S. pneumoniae, H. influenzae, S. aureus, and group A Streptococcus (1, 4).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [1] Lee EH, Wu C, Lee EU, et al. Fatalities associated with the 2009 H1N1 influenza A virus in New York city. Clin Infect Dis. 2010;50:1498–504. source
Not checked in the free run.
- cites [4] Busi RE, Schinina V, Ferraro F, et al. Radiological findings of pneumonia in patients with swine-origin influenza A virus (H1N1). Radiol Med. 2010;115:507–15. source
Not checked in the free run.
- Premisecitation
ECMO use is associated with high rates of survival.
“The use of ECMO rose sharply in 2009 and is associated with high rates of survival [47].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [47] Bridges B, Rycus P, Fonnesbeck C, Fleming G, Halasa N. Global trends in Extracorporeal membranous Oxygenation use and survival of patients with Influenza-associated illness. Pediatr Crit Care Med. 2016;17:876–83. source
Not checked in the free run.
- Premisecitation
The use of ECMO rose sharply in 2009.
“The use of ECMO rose sharply in 2009 and is associated with high rates of survival [47].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [47] Bridges B, Rycus P, Fonnesbeck C, Fleming G, Halasa N. Global trends in Extracorporeal membranous Oxygenation use and survival of patients with Influenza-associated illness. Pediatr Crit Care Med. 2016;17:876–83. source
Not checked in the free run.
- Premisecitation
Availability of antibiotics, critical care and extra-corporeal membrane oxygenation (ECMO) have vastly improved survival during a contemporary pandemic.
“availability of antibiotics, critical care and extra-corporeal membrane oxygenation (ECMO) have vastly improved survival during a contemporary pandemic, so it would be unlikely that case fatality rates of 1918 would recur in the modern era [45]”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [45] Bishop JF, Murnane MP, Owen R. Australia’s winter with the 2009 pandemic influenza A (H1N1) virus. N Engl J Med. 2009;361:2591–4 Epub 2009/11/27. source
Not checked in the free run.
- Premisecitation
The 2009 pandemic had high intensive care unit (ICU) occupancy rates.
“a low average age of death in fatal cases (53 years compared to 83 years during seasonal influenza) and high intensive care unit (ICU) occupancy rates [45]”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [45] Bishop JF, Murnane MP, Owen R. Australia’s winter with the 2009 pandemic influenza A (H1N1) virus. N Engl J Med. 2009;361:2591–4 Epub 2009/11/27. source
Not checked in the free run.
- Premisecitation
Among 1918 pandemic influenza cases without pneumonia, culture positivity rates were very low (mean <1%).
“Culture positivity rates among influenza cases without pneumonia was very low (mean < 1%), compare to those with pneumonia (mean, 16%; range, 2 to 50) [48].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [48] Chien Y-W, Klugman KP, Morens DM. Bacterial pathogens and death during the 1918 influenza pandemic. N Engl J Med. 2009;361:2582–3. source
Not checked in the free run.
- Premisecitation
Among 1918 pandemic influenza cases with pneumonia, culture positivity rates were mean 16% (range 2 to 50).
“Culture positivity rates among influenza cases without pneumonia was very low (mean < 1%), compare to those with pneumonia (mean, 16%; range, 2 to 50) [48].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [48] Chien Y-W, Klugman KP, Morens DM. Bacterial pathogens and death during the 1918 influenza pandemic. N Engl J Med. 2009;361:2582–3. source
Not checked in the free run.
- Premisecitation
More than 92% of autopsy lung cultures were positive for at least one bacterium in 3074 subjects from 68 high quality autopsy case series during the 1918 pandemic.
“This showed that more than 92% of autopsy lung cultures were positive for at least one bacterium [10].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [10] Morens DM, Taubenberger JK, Fauci AS. Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness. J Infect Dis. 2008;198:962–70 Epub 2008/08/20. source
Not checked in the free run.
- Interpretationreasoning
It is unlikely that case fatality rates of 1918 would recur in the modern era.
“so it would be unlikely that case fatality rates of 1918 would recur in the modern era [45]”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [45] Bishop JF, Murnane MP, Owen R. Australia’s winter with the 2009 pandemic influenza A (H1N1) virus. N Engl J Med. 2009;361:2591–4 Epub 2009/11/27. source
Not checked in the free run.
- Premisecitation
Histologic evidence of severe bacterial pneumonia was found in almost all of 58 lung tissue samples collected during the 1918 influenza pandemic.
“Morens et al. reviewed autopsy data from 58 lung tissue samples collected during the 1918 influenza pandemic and histologic evidence of severe bacterial pneumonia was found in almost all samples [10].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [10] Morens DM, Taubenberger JK, Fauci AS. Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness. J Infect Dis. 2008;198:962–70 Epub 2008/08/20. source
Not checked in the free run.
- Premisecitation
The polysaccharide vaccine has efficacy against invasive pneumococcal disease.
“and the polysaccharide vaccine also has efficacy against invasive pneumococcal disease [51].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [51] Jackson LA, Neuzil KM, Yu O, et al. Effectiveness of pneumococcal polysaccharide vaccine in older adults. N Engl J Med. 2003;348:1747–55. source
Not checked in the free run.
- Premisecitation
The WHO guidelines on vaccines and antivirals for a pandemic, along with many country-specific pandemic plans, do not consider pneumococcal vaccines.
“The WHO guidelines on vaccines and antivirals for a pandemic, along with many country-specific pandemic plans, do not consider pneumococcal vaccines [49].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [49] World Health Organisation (WHO). WHO guidelines on the use of vaccines and antivirals during influenza pandemics. 2004.
Not checked in the free run.
- Premisecitation
The CAPITA trial shows efficacy of conjugate pneumococcal vaccine against pneumonia.
“The CAPITA trial shows efficacy of conjugate pneumococcal vaccine against pneumonia [50]”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [50] Bonten M, Bolkenbaas M, Huijts S, et al. Community acquired pneumonia immunisation trial in adults (CAPITA). Pneumonia. 2014;3:95.
Not checked in the free run.
- Interpretationown data
The 19% bacterial co-infection rate in this review is comparable to Chien et al.
“Bacterial co-infection rates among hospitalised cases with confirmed pneumonia in this study was 19%, which is comparable to Chien et al.”
Quote in the paperNot a substantial claim - Premisecitation
Vaccination against Streptococcus pneumoniae is often neglected in pandemic planning.
“Vaccination against streptococcus pneumonia is often neglected in pandemic planning [52], but could have a positive impact on morbidity and mortality.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [52] Itzwerth R. Pandemic influenza and critical infrastructure. Sydney: University of New South Wales (UNSW); 2013.
Not checked in the free run.
- Interpretationreasoning
Improving uptake of routine pneumococcal vaccination in adults with an indication will cover most patients at risk.
“Improving uptake of routine pneumococcal vaccination in adults with an indication will cover most patients at risk, and may reduce the impact of a pandemic.”
Quote in the paperSubstantial claim - Interpretationreasoning
Vaccination against Streptococcus pneumoniae could have a positive impact on morbidity and mortality during a pandemic.
“Vaccination against streptococcus pneumonia is often neglected in pandemic planning [52], but could have a positive impact on morbidity and mortality.”
Quote in the paperSubstantial claim - Interpretationreasoning
The rate of bacterial co-infection may be underestimated because many cases are not tested for bacterial infections.
“The rate of bacterial co-infection may be underestimated as many cases are not tested for bacterial infections, and bacterial pneumonia cannot always be differentiated from viral pneumonia on the basis of clinical presentation, radiology and routine blood tests.”
Quote in the paperNot a substantial claim- Rests on an assumption: Bacterial pneumonia cannot always be differentiated from viral pneumonia on the basis of clinical presentation, radiology and routine blood tests.
- Interpretationreasoning
Improving uptake of routine pneumococcal vaccination in adults with an indication may reduce the impact of a pandemic.
“Improving uptake of routine pneumococcal vaccination in adults with an indication will cover most patients at risk, and may reduce the impact of a pandemic.”
Quote in the paperSubstantial claim
- Classified as probably not a substantial claim. 16
- May combine two claims. 11
Probably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataSeventy-five studies met the inclusion criteria for the systematic review.
“Seventy five studies met the inclusion criteria.”
- Also stated in: § Summary of included studies · plain
“75 studies met the inclusion criteria.”
Quote in the paperNot a substantial claim- Also stated in: § Summary of included studies · plain
May combine two claims.
FindingcitationIn a large study in Argentina (n=337), 24% of ICU patients with ILI and ARF requiring mechanical ventilation had bacterial pneumonia on admission, and 8% had S. pneumoniae.
“In a large study involving admissions to 35 ICUs for ILI and ARF requiring mechanical ventilation in Argentina (n = 337), 24% of included patients had bacterial pneumonia on admission, 8% with S. pneumoniae [5].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [5] Estenssoro E, Rios FG, Apezteguia C, et al. Pandemic 2009 influenza A in Argentina: a study of 337 patients on mechanical ventilation. Am J Respir Crit Care Med. 2010;182:41–8. source
Not checked in the free run.
May combine two claims.
FindingcitationIn a study in Argentina, bacteria were found in 76% of nasopharyngeal samples (152/199), of which Streptococcus pneumoniae was isolated in 31% (62/199).
“Palacios et al. conducted a study in Argentina and bacteria was found in 76% of nasopharyngeal samples (152/199), of which Streptococcus pneumoniae was isolated in 31% (62/199) samples [42].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [42] Palacios G, Hornig M, Cisterna D, et al. Streptococcus pneumoniae coinfection is correlated with the severity of H1N1 pandemic influenza. PLoS One. 2009;4:1–5. source
Not checked in the free run.
May combine two claims.
FindingcitationOf the eight autopsy case series, three studies tested lung tissue specimens for evidence of bacterial infection in all included subjects and identified bacterial co-infection in between 29 and 43% of fatal cases.
“Of the eight autopsy case series, 3 studies tested lung tissue specimens for evidence of bacterial infection in all included subjects [16–18] and identified bacterial co-infection diagnosed either before or after death in between 29 and 43% of fatal cases [16–18].”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [16] Centers for Disease Control and Prevention. Bacterial coinfections in lung tissue specimens from fatal cases of 2009 pandemic influenza A (H1N1) - United States, May–August 2009. MMWR Morb Mortal Wkly Rep. 2009;58:1071–4.
Not checked in the free run.
- cites [17] Mauad T, Hajjar LA, Callegari GD, et al. Lung pathology in fatal novel human influenza A (H1N1) infection. Am J Respir Crit Care Med. 2010;181:72–9. source
Not checked in the free run.
- cites [18] Shieh W-J, Blau DM, Denison AM, et al. 2009 pandemic influenza A (H1N1): pathology and pathogenesis of 100 fatal cases in the United States. Am J Pathol. 2010;177:166–75. source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Findingnone givenIt was not clear in many studies if pneumonia was community or hospital acquired.
“It was not clear in many studies if pneumonia was community or hospital acquired.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataIn these 9 studies, Acinobacter baumanii was the next most commonly identified bacteria (5-21%), followed by MRSA (3-6%), S. pneumoniae (2-4%) and K. Pneumonia in (1-8%).
“In these 9 studies, Acinobacter baumanii was the next most commonly identified bacteria (5–21%), followed by MRSA (3–6%), S. pneumoniae (2–4%) and K. Pneumonia in (1–8%).”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
FindingcitationIn the Korean study of standardised case reports of A(H1N1)pdm09-associated deaths, the estimated ILI case-fatality rate was 16 per 100,000 cases.
“The Korean study of standardised case reports of A(H1N1)pdm09-associated deaths identified during a period of active surveillance estimated ILI case-fatality rate to be 16 per 100,000 cases [20].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [20] Kim HS, Kim JH, Shin SY, et al. Fatal cases of 2009 pandemic influenza A (H1N1) in Korea. J Korean Med Sci. 2011;26:22–7. source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
FindingcitationThe mPCR assay did not test for S. pneumoniae in one study and the authors could not report the presence of this organism.
“However, the mPCR assay did not test for S. pneumoniae in one study and the authors could not report the presence of this organism [23].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [23] Perez-Padilla R, De La Rosa-Zamboni D, Ponce De Leon S, et al. Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico. N Engl J Med. 2009;361:680–9. source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Findingown dataEleven studies included only PCR confirmed A(H1N1)pdm09 cases, while three included probable cases and another three included both probable and suspected cases.
“Eleven studies included only PCR confirmed A(H1N1)pdm09 cases, while three included probable cases [31, 39, 40] and another three included both probable and suspected cases [5, 33, 34].”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Findingown dataAlmost all studies of hospitalised cases not requiring ICU include patients admitted to general wards, however some were transferred to ICU during the course of treatment.
“Almost all studies include patients admitted to general wards, however some were transferred to ICU during the course of treatment.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataCriteria for admission to ICU varied in the included studies.
“Criteria for admission to ICU varied in the included studies, including acute respiratory distress (ARD) [26, 27], acute respiratory failure [28, 29], required mechanical ventilation (MV) [5, 30, 31] or MV or low O2/IV vasoconstrictive drugs [32, 33], MV or ECMO [34] or admitted with no criteria provided [35–41].”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingnone givenProbable cases (13/75 studies) included those with positive influenza A serology during 2009-2010, but not testing of subtype.
“Probable cases (13/75 studies) included those with positive influenza A serology during 2009–2010, but not testing of subtype.”
Quote in the paperNot a substantial claimMay combine two claims.
FindingcitationThe study conducted in Mexico early in the pandemic isolated ventilator-associated bacteria in 4 (22%) cases, with Acinetobacter baumannii, Achromobacter xylosoxidans, methicillin-resistant Staphylococcus aureus, and Escherichia coli identified.
“The study conducted in Mexico early in the pandemic [23] isolated ventilator-associated bacteria in 4 (22%) cases, with Acinetobacter baumannii, Achromobacter xylosoxidans, methicillin-resistant Staphylococcus aureus, and Escherichia coli identified.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [23] Perez-Padilla R, De La Rosa-Zamboni D, Ponce De Leon S, et al. Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico. N Engl J Med. 2009;361:680–9. source
Not checked in the free run.
May combine two claims.
Findingnone givenRates of bacterial infection were higher in adults, ICU patients, and those with a fatal outcome.
“with higher rates in adults, ICU patients and those with a fatal outcome”
- Also stated in: § Conclusion · hedged
“with higher rates in adults, ICU patients and those with a fatal outcome”
Quote in the paperSubstantial claim- Also stated in: § Conclusion · hedged
May combine two claims.
Findingnone givenThe prevalence of bacterial co-infection was lower in studies of hospitalized patients not requiring ICU and in studies of paediatric hospitalized patients, although the latter was quite varied.
“The prevalence of bacterial co-infection was lower in studies of hospitalized patients not requiring ICU and in studies of paediatric hospitalized patients, although the latter was quite varied.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductcitationThe systematic review was conducted according to the Preferred Reporting Items for Systematic Reviews (PRISMA).
“A systematic review was conducted according to the Preferred Reporting Items for Systematic Reviews (PRISMA) [12].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [12] Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg. 2010;8:336–41. source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenAll potentially relevant papers were read by two reviewers to determine those which met the selection criteria.
“All potentially relevant papers were read by two reviewers (AH, MB) to determine those which met the selection criteria.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataFive reviewers independently reviewed titles and abstracts to identify potentially relevant papers.
“Five reviewers (AH, MB, RT, IR,, HS,) with experience in conducting systematic reviews independently reviewed the titles and abstracts to identify potentially relevant papers.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim.
Study design and conductnone givenPneumonia, hospital admission and ICU admission were accepted according to classification in the reviewed papers.
“Pneumonia, hospital admission and ICU admission were accepted according to classification in the reviewed papers.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationBacterial pathogens in the respiratory tract may also predispose to influenza and other viral infection.
“Conversely, bacterial pathogens in the respiratory tract may also predispose to influenza and other viral infection [9].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [9] Madhi SA, Klugman KP. A role for Streptococcus pneumoniae in virus-associated pneumonia. Nat Med. 2004;10:811–3 Epub 2004/07/13. source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenDiscrepancies between reviewers were discussed with an independent senior reviewer.
“All findings, including discrepancies between reviewers were discussed with an independent senior reviewer (CRM).”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductreasoningEach study was independently data extracted by two reviewers.
“To ensure consistency in data extraction, each study was independently data extracted by two reviewers.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationA UK study showed a "w" shaped morbidity curve with a peak in young adults.
“a UK study showed a “w” shaped morbidity curve with a peak in young adults [46]”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [46] Myles PR, Semple MG, Lim WS, et al. Predictors of clinical outcome in a national hospitalised cohort across both waves of the influenza A/H1N1 pandemic 2009–2010 in the UK. Thorax. 2012;67:709–17. source
Not checked in the free run.
May combine two claims.
PremisecitationThe average age of death in fatal cases during the 2009 pandemic was 53 years, compared to 83 years during seasonal influenza.
“a low average age of death in fatal cases (53 years compared to 83 years during seasonal influenza) and high intensive care unit (ICU) occupancy rates [45]”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [45] Bishop JF, Murnane MP, Owen R. Australia’s winter with the 2009 pandemic influenza A (H1N1) virus. N Engl J Med. 2009;361:2591–4 Epub 2009/11/27. source
Not checked in the free run.
The paper relies on this without support.
The association between bacterial complications and serious outcomes is causal, such that preventing or treating bacterial secondary infection would reduce death and ICU admission.
“Bacterial complications were associated with serious outcomes such as death and admission to intensive care. Prevention and treatment of bacterial secondary infection should be an integral part of pandemic planning, and improved uptake of routine pneumococcal vaccination in adults with an indication may reduce the impact of a pandemic.”
The paper relies on this without support.
Bacterial pneumonia cannot always be differentiated from viral pneumonia on the basis of clinical presentation, radiology and routine blood tests.
“bacterial pneumonia cannot always be differentiated from viral pneumonia on the basis of clinical presentation, radiology and routine blood tests”
The paper relies on this without support.
Currently there are limited data on bacterial coinfection during influenza pandemic in 1918.
“Currently there are limited data on bacterial coinfection during influenza pandemic in 1918.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Bacterial complications increased morbidity and mortality of influenza infection.
“Epidemiological data indicated that bacterial complications further increased morbidity and mortality of influenza infection.”
From Oral Microbiome and SARS-CoV-2: Beware of Lung Co-infection (2020) · cites this paper as MacIntyre et al., 2018
During the 2009 influenza pandemic, almost one in four patients presented bacterial complications.
“During the 2009 influenza pandemic, almost one in four patients presented bacterial complications (MacIntyre et al., 2018).”
From Oral Microbiome and SARS-CoV-2: Beware of Lung Co-infection (2020) · cites this paper as MacIntyre et al., 2018
Bacterial complications were an important complication of the 2009 influenza pandemic.
“bacterial complications were an important complication of the 2009 influenza pandemic (MacIntyre et al., 2018).”
From Oral Microbiome and SARS-CoV-2: Beware of Lung Co-infection (2020) · cites this paper as MacIntyre et al., 2018
Similar to SARS, conditional pathogens were the most common infectious microbes in influenza.
“Similar to SARS, conditional pathogens were the most common infectious microbes (Muscedere et al., 2013; MacIntyre et al., 2018).”
From Oral Microbiome and SARS-CoV-2: Beware of Lung Co-infection (2020) · cites this paper as MacIntyre et al., 2018
In the 2009 influenza pandemic, 1 in 4 severe or fatal cases of influenza A(H1N1)pdm09 had a bacterial infection.
“In the 2009 influenza pandemic, 1 in 4 severe or fatal cases of influenza A(H1N1)pdm09 had a bacterial infection, with an apparent association with morbidity and mortality.”
From Co-infections in people with COVID-19: a systematic review and meta-analysis. (2020) · cites this paper as [43]
The bacteria most commonly associated with influenza infection are those which commonly colonise the nasopharynx, such as Streptococcus pneumoniae, Staphylococcus aureus, and Streptococcus pyogenes, with secondary infection usually occurring in the first 6 days of influenza.
“The bacteria most commonly associated with influenza infection have been reported to be those which commonly colonise the nasopharynx, such as Streptococcus pneumoniae, Staphylococcus aureus, and Streptococcus pyogenes, with secondary infection usually occurring in the first 6 days of influenza.43, 44, 45”
From Co-infections in people with COVID-19: a systematic review and meta-analysis. (2020) · cites this paper as [43]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Zero pneumococcal cases are labelled 100%
MajorThe Choi row reports zero cases among 17 patients but labels this as 100%. The percentage is 0%.
Reported 100 · recomputed 0
“0/17 (100)Testing for S. pneumo”
Zero bacterial-positive cases are labelled 19%
MajorThe Koegelenberg row reports 0 of 19 patients with positive bacterial growth but gives a rate of 19%. The rate is 0%.
Reported 19 · recomputed 0
“0/19 (19)”
Paediatric pneumonia percentage does not match its count
MinorThe Kumar row gives 23 of 75 patients with pneumonia, which is 30.7%, not 34.3%.
Reported 34.3 · recomputed 30.666667
“23/75 (34.3)- CXR- Diff”
All Shin patients admitted to ICU are labelled 0%
MinorThe paediatric table lists 30 of 30 patients as requiring ICU but gives the percentage as 0%.
Reported 0 · recomputed 100
“30/30 (0)”
Kumar invasive-ventilation percentage uses a different denominator
MinorThe reported 94.1% corresponds to 128 of the 136 mechanically ventilated patients. With the printed denominator of 168, the percentage is 76.2%.
Reported 94.1 · recomputed 76.190476
“136/168 (81.0)- IV = 128/168 (94.1)”
Torres bacterial-positive percentage is understated
MinorOne positive case among 11 patients is 9.1%, not 0.9%.
Reported 0.9 · recomputed 9.090909
“1/11 (0.9)Group A StreptococcusSite NR”
Miller death percentage is understated
MinorEight deaths among 47 patients is 17.0%, not 14%.
Reported 14 · recomputed 17.021277
“8/47 (14)”
Rice invasive-ventilation percentage uses a different denominator
MinorThe printed denominator gives 175 of 683 patients, or 25.6%, not 75.8%. The reported percentage instead corresponds to 175 of the 231 mechanically ventilated patients; the adjacent noninvasive-ventilation figure has the same denominator mismatch.
Reported 75.8 · recomputed 25.622255
“231/683 (33.8)- IV = 175/683 (75.8)- NIV = 56/683 (24.2)”
Miller invasive-ventilation denominator conflicts with its percentage
MinorThe reported 84.6% corresponds to 11 of the 13 mechanically ventilated patients, not the printed denominator of 47. Eleven of 47 is 23.4%.
Reported 84.6 · recomputed 23.404255
“13/47 (27.7)IV = 11/47 (84.6)”
Fatal-case ventilation percentage uses the wrong denominator
MinorThe table reports 25 of 47 cases requiring mechanical ventilation, which is 53.2%, not 80.6%.
Reported 80.6 · recomputed 53.191489
“25/47 (80.6)”
Kim ventilation percentage is labelled 100%
MinorThe row reports mechanical ventilation for 162 of 245 patients, or 66.1%, rather than 100%.
Reported 100 · recomputed 66.122449
“162/245 (100)”
Champunot death percentage is understated
MinorFive deaths among 24 patients is 20.8%, not 8.3%.
Reported 8.3 · recomputed 20.833333
“5/24 (8.3)”
Randolph ventilation percentage uses a different denominator
MinorThe row reports mechanical ventilation for 546 of 838 patients, or 65.2%, rather than 67.3%.
Reported 67.3 · recomputed 65.155131
“546/838 (67.3)”
Roch ventilation percentage uses the wrong denominator
MinorTen of 18 patients is 55.6%, not the reported 100%.
Reported 100 · recomputed 55.555556
“10/18 (100)”
The citation lists haven’t been fetched yet
References 95 · Cited by 323
Research works printed but not linked: 3
- World Health Organisation (WHO). WHO guidelines on the use of vaccines and antivirals during influenza pandemics. 2004.
- Bonten M, Bolkenbaas M, Huijts S, et al. Community acquired pneumonia immunisation trial in adults (CAPITA). Pneumonia. 2014;3:95.
- Itzwerth R. Pandemic influenza and critical infrastructure. Sydney: University of New South Wales (UNSW); 2013.
- Authors
- MacIntyre, C. R., Chughtai, A. A., Barnes, M., Ridda, I., Seale, H., Toms, R., & Heywood, A.
- Affiliations
- UNSW Sydney (AU)
- Corresponding author
- Chughtai, Abrar Ahmad
- Venue
- BMC Infectious Diseases
- Published
- 2018-12
- Volume
- 18
- Issue
- 1
- Pages
- 637-637
- ISSN
- 1471-2334 (ISSN-L)
- PMC
- PMC6286525
- OpenAlex
- W2904662596
- Semantic Scholar
- 4d4b190eef71b868c0a593be894c4cdbe3d5012c
- Cited by
- 323
- References
- 95
- Citations by year
- 2026: 12 · 2025: 13 · 2024: 38 · 2023: 48 · 2022: 59 · 2021: 73 · 2020: 72 · 2019: 8
- FWCI
- 29.74
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- BMC Infectious Diseases (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- UNSWorks (University of New South Wales, Sydney, Australia) (submittedVersion, cc-by-nc-nd)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Epidemiology › Influenza Virus Research Studies
- Health Sciences › Medicine › Epidemiology › Pneumonia and Respiratory Infections
- Health Sciences › Medicine › Epidemiology › Respiratory viral infections research
- Keywords
- influenza A(H1N1)pdm09, 2009 H1N1 pandemic, secondary bacterial infection, pneumonia, Streptococcus pneumoniae, bacterial co-infection, fatal outcome, intensive care unit admission, pediatric patients, pneumococcal vaccination, bacterial complications
- MeSH terms
- Adult, Bacterial Infections, Child, Humans, Influenza, Human, Mortality, Pneumonia, Severity of Illness Index, Prevalence, History, 21st Century, Influenza A Virus, H1N1 Subtype, Pandemics, Coinfection
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-09.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-09.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review